Sign In

HFS logo


Provider Notice Issued 12/08/2022

Date:   December 8, 2022

To:       All Medical Assistance Program Providers      

Re:      Confirmation of No Copayment for Naloxone Effective January 1, 2023, per Public Act 102-1038

___________________________________________________________________________________________________________________________________________________

This notice confirms the Department of Healthcare and Family Services (HFS) will not charge a customer copayment for Naloxone pursuant to Public Act 102-1038. This applies to customers covered under HFS' fee-for-service (FFS) program and the managed care organization (MCO) plans.

The Act states that HFS shall not impose a copayment on the coverage provided for Naloxone Hydrochloride under the Medical Assistance program. This notice verifies that pharmacies dispensing Naloxone will not charge a drug copayment for this medication under any of HFS' Medical Programs.

Questions regarding this notice may be directed to the Bureau of Professional and Ancillary Services at 877-782-5565 for FFS claims, or the applicable MCO plan.

 
Kelly Cunningham, Administrator
Division of Medical Programs 



Notices

 Need Assistance?



Illinois Department of Healthcare and Family Services

JB Pritzker, Governor • Theresa Eagleson, Director




We improve lives.